Last $36.42 USD
Change Today +0.85 / 2.39%
Volume 1.4M
MYGN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for myriad genetics inc (MYGN)

Year over year, Myriad Genetics Inc. has been able to grow revenues from $613.2M USD to $778.2M USD. Most impressively, the company has been able to reduce the percentage of sales devoted to income tax expense from 14.05% to 13.06%. This was a driver that led to a bottom line growth from $147.1M USD to $176.2M USD.
Currency in
Millions of US Dollars
As of:Jun 30
2011
Restated
Jun 30
2012
Restated
Jun 30
2013
Jun 30
2014
4 Year
Trend
Revenues402.1496.0613.2778.2
TOTAL REVENUES402.1496.0613.2778.2
Cost of Goods Sold46.764.779.6108.8
GROSS PROFIT355.4431.3533.5669.4
Selling General & Admin Expenses, Total169.8208.4251.8318.7
R&D Expenses27.842.652.263.7
OTHER OPERATING EXPENSES, TOTAL197.6251.0304.1382.4
OPERATING INCOME157.8180.3229.5287.1
Interest and Investment Income2.24.65.55.4
NET INTEREST EXPENSE2.24.65.55.4
Other Non-Operating Income (Expenses)-0.4-0.4-0.2-2.0
EBT, EXCLUDING UNUSUAL ITEMS159.7184.5234.8290.5
Merger & Restructuring Charges-------12.6
Other Unusual Items, Total-----1.5--
EBT, INCLUDING UNUSUAL ITEMS159.7184.5233.3277.9
Income Tax Expense58.972.486.1101.6
Earnings from Continuing Operations100.7112.2147.1176.2
NET INCOME100.7112.2147.1176.2
NET INCOME TO COMMON INCLUDING EXTRA ITEMS100.7112.2147.1176.2
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS100.7112.2147.1176.2
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MYGN:US $36.42 USD +0.85

MYGN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Advanced Drainage Systems Inc $22.55 USD +0.43
Bio-Reference Laboratories Inc $29.91 USD -0.44
Foundation Medicine Inc $24.07 USD +1.89
Genomic Health Inc $31.31 USD -0.13
Imperial Innovations Group PLC 450.00 GBp +2.50
View Industry Companies
 

Industry Analysis

MYGN

Industry Average

Valuation MYGN Industry Range
Price/Earnings 20.4x
Price/Sales 3.6x
Price/Book 3.7x
Price/Cash Flow 19.4x
TEV/Sales 3.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MYRIAD GENETICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.